These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35458581)

  • 1. Ageritin-The Ribotoxin-like Protein from Poplar Mushroom (
    Rotondo R; Ragucci S; Castaldo S; Landi N; Oliva MA; Pedone PV; Di Maro A; Arcella A
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification, characterization and cytotoxicity assessment of Ageritin: The first ribotoxin from the basidiomycete mushroom Agrocybe aegerita.
    Landi N; Pacifico S; Ragucci S; Iglesias R; Piccolella S; Amici A; Di Giuseppe AMA; Di Maro A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1113-1121. PubMed ID: 28232091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal Activity of Ageritin, a Ribotoxin-like Protein from
    Ragucci S; Castaldi S; Landi N; Isticato R; Di Maro A
    Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37756004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ageritin from Pioppino Mushroom: The Prototype of Ribotoxin-Like Proteins, a Novel Family of Specific Ribonucleases in Edible Mushrooms.
    Ragucci S; Landi N; Russo R; Valletta M; Pedone PV; Chambery A; Di Maro A
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33917246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and enzymatic properties of Ageritin, a novel metal-dependent ribotoxin-like protein with antitumor activity.
    Ruggiero A; García-Ortega L; Ragucci S; Russo R; Landi N; Berisio R; Di Maro A
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2888-2894. PubMed ID: 30262416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous Production and Functional Characterization of Ageritin, a Novel Type of Ribotoxin Highly Expressed during Fruiting of the Edible Mushroom Agrocybe aegerita.
    Tayyrov A; Azevedo S; Herzog R; Vogt E; Arzt S; Lüthy P; Müller P; Rühl M; Hennicke F; Künzler M
    Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31444206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR.
    Staffieri S; Russo V; Oliva MA; Alborghetti M; Russo M; Arcella A
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNAP reverses temozolomide resistance in human glioblastoma multiforme cells through down-regulation of MGMT.
    Tsai CK; Huang LC; Wu YP; Kan IY; Hueng DY
    FASEB J; 2019 Dec; 33(12):14171-14184. PubMed ID: 31725331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.
    Yang B; Ma YB; Chu SH
    Cancer Gene Ther; 2018 Dec; 25(11-12):309-316. PubMed ID: 30140041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.
    Agnihotri S; Gajadhar AS; Ternamian C; Gorlia T; Diefes KL; Mischel PS; Kelly J; McGown G; Thorncroft M; Carlson BL; Sarkaria JN; Margison GP; Aldape K; Hawkins C; Hegi M; Guha A
    J Clin Invest; 2012 Jan; 122(1):253-66. PubMed ID: 22156195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ageritin, a Ribotoxin from Poplar Mushroom ( Agrocybe aegerita) with Defensive and Antiproliferative Activities.
    Citores L; Ragucci S; Ferreras JM; Di Maro A; Iglesias R
    ACS Chem Biol; 2019 Jun; 14(6):1319-1327. PubMed ID: 31136705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency.
    Montaldi AP; Lima SCG; Godoy PRDV; Xavier DJ; Sakamoto-Hojo ET
    Oncol Rep; 2020 Nov; 44(5):2275-2287. PubMed ID: 32901889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
    Lombardi F; Augello FR; Artone S; Gugu MK; Cifone MG; Cinque B; Palumbo P
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status.
    Vázquez-Blomquist D; Leenstra S; van der Kaaij M; Villarreal A; Bello-Rivero I
    Mol Biol Rep; 2020 Jul; 47(7):5263-5271. PubMed ID: 32607953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
    Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning with INC280 and LDK378 drugs sensitizes MGMT-unmethylated glioblastoma to temozolomide: Pre-clinical assessment.
    Das A; Alshareef M; Porto GBF; Infinger LK; Vandergrift WA; Lindhorst SM; Varma AK; Patel SJ; Cachia D
    J Neurol Sci; 2020 Nov; 418():117102. PubMed ID: 32866816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression.
    Kohsaka S; Wang L; Yachi K; Mahabir R; Narita T; Itoh T; Tanino M; Kimura T; Nishihara H; Tanaka S
    Mol Cancer Ther; 2012 Jun; 11(6):1289-99. PubMed ID: 22532597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O
    Dehghani-Soltani S; Eftekhar-Vaghefi SH; Babaee A; Basiri M; Mohammadipoor-Ghasemabad L; Vosough P; Ahmadi-Zeidabadi M
    Cancer Biother Radiopharm; 2021 Sep; 36(7):579-587. PubMed ID: 32644826
    [No Abstract]   [Full Text] [Related]  

  • 19. MGMT-inhibitor in combination with TGF-βRI inhibitor or CDK 4/6 inhibitor increases temozolomide sensitivity in temozolomide-resistant glioblastoma cells.
    Das A; Henderson FC; Alshareef M; Porto GBF; Kanginakudru I; Infinger LK; Vandergrift WA; Lindhorst SM; Varma AK; Patel SJ; Cachia D
    Clin Transl Oncol; 2021 Mar; 23(3):612-619. PubMed ID: 32710211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Organization, Expression, and Localization of Ribotoxin-Like Protein Ageritin in Fruiting Body and Mycelium of
    Baglivo I; Ragucci S; D'Incecco P; Landi N; Russo R; Faoro F; Pedone PV; Di Maro A
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.